Maanasi Samant

Maanasi Samant

Auto-generated profile, based on publicly available information

Maanasi Samant

Northwestern University Feinberg School of Medicine

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2023 in Chest
Verified
Journal Article
Closed access
MSMaanasi Samant
Maanasi Samant
JKJames G. Krings
James G. Krings
DLDaphne Lew
Daphne Lew
CGCharles W. Goss
Charles W. Goss
TKTammy Koch
Tammy Koch
MCMario Castro
Mario Castro

13 November 2025 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
JKJason Katz
Jason Katz
KCKelley Chen
Kelley Chen
MCMichael J. Cuttica
Michael J. Cuttica
RMRuben Mylvaganam
Ruben Mylvaganam
YRYasmin Raza
Yasmin Raza
DSDaniel R. Schimmel
Daniel R. Schimmel
Balloon pulmonary angioplasty (BPA) is the treatment of choice for patients with chronic thromboembolic pulmonary hypertension who cannot receive pulmonary thromboendarterectomy or who have residual pulmonary hypertension after pulmonary thromboendarterectomy. As BPA volume and expertise have increased, significant strides in refining this technique have improved success and minimized complications; yet, minimal literature exists on appropriate complication management. This review summarizes how interventionalists can prevent, recognize, and manage BPA complications effectively. Operators must first focus on appropriate patient and vessel selection. Lower lung zones coupled with ring-like stenoses and web lesions are more favorable. Increased patient age, tortuous or subtotal lesions, and elevated pulmonary vascular resistance (>6 Wood units) portend a higher risk for complications. Vascular perforation can be treated with balloon tamponade, embolization (gelfoam and/or coils), and covered stents. Massive hemoptysis is managed with intubation and single lung ventilation if needed. As shock is predominantly hemorrhagic and/or cardiogenic, first-line therapies include vasopressors, inodilators, pulmonary vasodilators, and volume resuscitation, whereas mechanical support devices are second-line. Although reperfusion lung injury (RLI) is uncommon, it is generally well tolerated and managed with positive pressure ventilation, high-flow oxygen therapy, and diuresis. Acute kidney injury can be reduced by dilution of contrast dye, use of extension catheters, and procedural planning. Utilization of standard, angle-minimizing techniques, avoidance of high-dose cinefluoroscopy, and digital subtraction angiography minimizes radiation dose. In conclusion, most complications can be avoided or managed effectively without major morbidity or mortality by optimal preparation, patient selection, and commitment to a comprehensive BPA program.

23 October 2025 in Journal of Intensive Care Medicine
Verified
Journal Article
Closed access
CPClare C. Prohaska
Clare C. Prohaska
MYMaidah Yaqoob
Maidah Yaqoob
RRRaju Reddy
Raju Reddy
MSMaanasi Samant
Maanasi Samant
JLJustin K. Lui
Justin K. Lui
Pulmonary hypertension, characterized by elevated pressures in the pulmonary arteries leading to abnormalities in right ventricular function, may lead to competing demands between the pulmonary and systemic circulation during sepsis and septic shock. As a result, management of pulmonary hypertension in sepsis, including identifying the source of infection, maintaining hemodynamic stability and continuing or transitioning pulmonary hypertension-specific therapies can often be challenging. The goal of this review is to highlight factors to consider in the evaluation and management of patients with pulmonary hypertension and sepsis.

16 July 2026 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
KJKevin Jin
Kevin Jin
KCKelley Chen
Kelley Chen
BMBenjamin L. Magod
Benjamin L. Magod
ZMZhiying Meng
Zhiying Meng
HBHeather Byrd
Heather Byrd
DSDaniel R. Schimmel
Daniel R. Schimmel
Balloon pulmonary angioplasty (BPA) is increasingly used for patients with inoperable or residual chronic thromboembolic pulmonary hypertension. Overnight observation is the current standard practice. We evaluated the safety and feasibility of same-day discharge (SDD) after BPA at a contemporary US referral center. We retrospectively analyzed consecutive chronic thromboembolic pulmonary hypertension patients undergoing BPA between 2018 and 2024. SDD was defined as discharge on the calendar day of BPA. The primary outcome was 30-day readmission or mortality; secondary outcomes included BPA-related complications. Predictors of SDD were assessed using mixed-effects logistic regression. Seventy-seven patients underwent 262 BPA procedures; 89 (34%) were followed by SDD. Patients selected for SDD had higher baseline 6-minute walk distance (356 vs 270 m; P = .010). SDD procedures were shorter (89 vs 101 minutes; P < .001) and associated with lower mean pulmonary artery pressure (28.5 vs 34.9 mm Hg; P < .001). Overall, 30-day complication rates were low (6/262, 2.3%), with no periprocedural deaths. Thirty-day readmission rates were similar between SDD and non-SDD procedures (7.9% vs 4.0%; P = .43). In multivariable analysis, higher 6-minute walk distance (odds ratio [OR], 1.66 per 100 m; P = .026), device closure (OR, 6.33; P = .028), and larger balloon size (OR, 1.44 per mm; P = .037) were associated with SDD, whereas initial BPA session (OR, 0.13; P < .001) and longer procedure duration (OR, 0.66 per 10 minutes; P < .001) were associated with admission. Among patients meeting prespecified institutional eligibility criteria, SDD after BPA was feasible and not associated with increased 30-day adverse events. Structured SDD pathways guided by reproducible selection criteria may optimize resource utilization as BPA volumes continue to grow.

23 October 2025 in CHEST Pulmonary
Verified
Journal Article
Open access
MSMaanasi Samant
Maanasi Samant
NDNathan Droz
Nathan Droz
DLDaphne Lew
Daphne Lew
KMKaitlin Marquis
Kaitlin Marquis
KKKacie L. Kuykendall
Kacie L. Kuykendall
KSKristen M. Sanfilippo
Kristen M. Sanfilippo
The importance of clot burden on CT scan in determining outcomes in patients with pulmonary embolism (PE) is poorly studied. We sought to analyze the association between PE clot burden and outcomes in patients who underwent a PE response team activation. Does clot burden and distribution impact clinical outcomes in patients with PE? We performed a retrospective review of patients with PE response team activation between January 2021 and May 2022. Clot obstruction was scored according to percentage of obstructed surface of each central and peripheral vessel using the Mastora scoring system. Based on the median percentage of peripheral and central obstruction, we categorized patients into the following 4 groups: high peripheral only, high central only, high peripheral and central, and neither high peripheral nor high central clot obstruction. Outcomes included ICU transfer, need for pressors within 24 hours, cardiac arrest during admission, in-hospital mortality, and 30-day mortality. Significant associations were analyzed in a multivariable logistic regression model while controlling for potential confounders. A total of 140 patients met inclusion criteria and were analyzed. Most patients (n = 113, 81%) were treated with anticoagulant therapy alone, whereas 27 patients (19%) received mechanical thrombectomy plus anticoagulant therapy. Patients in the high peripheral only group had increased odds of suffering cardiac arrest during admission (OR, 4.17; 95% CI, 1.06-16.35). The association persisted in multivariable logistic regression (OR, 20.85; 95% CI, 2.85-152.55). The results of this study show that patients with high peripheral only clot burden have an increased risk of cardiac arrest during hospitalization for incident PE. As such, clot burden and location may be indicators to guide selection of PE-directed therapy. Future studies confirming our findings are warranted.